F. Zhang et al. / Tetrahedron 66 (2010) 6864e6868
6867
1H), 2.75e2.55 (m, 2H), 1.31 (s, 9H), 1.25 (t, J¼6.9 Hz, 3H); 13C NMR
(q, J¼6.9 Hz, 2H), 3.78e3.75 (m, 1H), 2.83e2.81 (m, 1H), 2.67e2.60
(m, 1H), 2.43e2.35 (m, 1H), 2.16e2.07 (m, 1H), 2.01e1.94 (m, 1H),
(CDCl3): d 174.4, 170.6, 137.9, 135.8, 129.0, 125.6, 61.2, 58.3, 38.8 (m),
32.9, 30.2, 22.7, 14.0; 19F NMR (CDCl3):
d
ꢀ71.09 (d, J¼5.3 Hz, 3F);
1.29e1.23 (m, 12H); 13C NMR (CDCl3):
d 170.8, 141.5, 129.0, 128.3,
ESI MS (m/z): 426 (Mþþ1); HRMS calcd for C18H23ClF3NNaO3S
[MþNaþ]: 448.0932; Found: 448.0937.
126.9, 61.2, 56.9, 56.2, 36.4 (m), 33.4, 22.6, 14.1; 19F NMR (CDCl3):
d
ꢀ71.70 (d, J¼8.7 Hz, 3F); ESI MS (m/z): 394 (Mþþ1); HRMS calcd
for C18H27F3NO3S [Mþþ1]: 394.1658; Found: 394.1671.
4.2.1.5. (S)-Ethyl 5-((R)-tert-butanesulfinylimino)-5-(4-nitrophen-
yl)-3-(trifluoromethyl)pentanoate (3e). Yellowish viscous oil, yield
4.2.3. Synthesis of 5a. Into a solution of 4a (30 mg, 0.08 mmol) in
CH3OH (2 mL) was added saturated HCl/Et2O solution (2 mL) slowly
at room temperature. After stirring for 0.5 h at room temperature,
CH2Cl2 (30 mL) was added. The mixture was washed with aqueous
sodium hydroxide (10 mLꢂ3, 1 N). Concentrating the combined
organic layer under vacuum afforded crude hydrolysis product.
Without further purification, this crude product was dissolved into
Et2O (2 mL). DABCO (1,4-diazabicyclo[2.2.2]octane, 8.5 mg,
0.08 mmol) was added at room temperature. After stirring at this
temperature for 1 h, the reaction mixture was concentrating under
vacuum. Pure 5a was obtained via flash column chromatography on
silica gel (pet. ether/EtOAc¼2/1) in the yield of 95%.
20
95%; [
a
]
þ28.9 (c 0.88, CHCl3); FTIR (KBr, cmꢀ1):
n 2983, 2930,
D
1737, 1599, 1526, 1349, 1268, 1160, 1118; 1H NMR (CDCl3):
d
8.33e8.30 (m, 2H), 8.03e8.00 (m, 2H), 4.16 (q, J¼6.6 Hz, 2H),
4.02e4.00 (m, 1H), 3.47e3.40 (m, 1H), 3.04e3.01 (m, 1H), 2.78e2.57
(m, 2H), 1.33 (s, 9H), 1.25 (t, J¼6.6 Hz, 3H); 13C NMR (CDCl3):
d 173.5,
170.7, 149.4, 142.8, 128.5, 123.9, 61.4, 58.9, 38.7 (m), 32.8, 30.3, 22.8,
14.3; 19F NMR (CDCl3):
d
ꢀ70.90 (d, J¼5.3 Hz, 3F); ESI MS (m/z): 437
(Mþþ1); HRMS calcd for C18H23F3N2NaO5S [MþNaþ]: 459.1170.
Found: 459.1180.
4.2.1.6. (S)-Ethyl 5-((R)-tert-butanesulfinylimino)-5-morpholino-
3-(trifluoromethyl)pentanoate (3f). Colorless crystal, yield 96%; mp
20
82e83 ꢁC; [
a]
ꢀ117.3 (c 0.95, CHCl3); FTIR (KBr, cmꢀ1):
n
2982,
4.2.3.1. (4S,6R)-6-Phenyl-4-(trifluoromethyl)piperidin-2-one
D
1737, 1540, 1481, 1359, 1301, 1256, 1207, 1113, 1057; 1H NMR
(5a). Colorless solid, yield 95%; mp 153e154 ꢁC; [ 20 64.1 (c 0.23,
a]
D
(CDCl3):
d
4.13 (q, J¼7.5 Hz, 2H), 3.77e3.68 (m, 5H), 3.57e3.39 (m,
CHCl3); FTIR (KBr, cmꢀ1):
1113, 1060; 1H NMR (CDCl3):
4.56e4.51 (m, 1H), 2.76e2.71 (m, 2H), 2.54e2.43 (m, 1H),
n
3214, 2926, 1625, 1474, 1402, 1270, 1175,
7.41e7.26 (m, 5H), 5.96 (br, 1H),
3H), 3.18e3.16 (m, 1H), 2.90e2.83 (m, 1H), 2.70e2.62 (m, 1H),
1.43e1.33 (m, 1H), 1.26 (t, J¼7.5 Hz, 3H), 1.19 (s, 9H); 19F NMR
d
(CDCl3):
d
ꢀ72.03 (d, J¼9.3 Hz, 3F); ESI MS (m/z): 401 (Mþþ1). Anal.
2.34e2.29 (m,1H),1.78e1.64 (m, 1H); 19F NMR (CDCl3):
d
ꢀ74.04 (d,
Calcd for C16H27F3N2O4S: C, 47.99; H, 6.80; N, 7.00. Found: C, 47.96;
H, 6.67; N, 6.95.
J¼8.7 Hz, 3F); ESI MS (m/z): 244 (Mþþ1). Anal. Calcd for
C12H12F3NO: C, 59.26; H, 4.97; N, 5.76. Found: C, 59.21; H, 5.17; N,
5.65.
4.2.1.7. Ethyl 5-((R)-tert-butylsulfinylimino)-6-methyl-3-(trifluoro-
methyl)heptanoate (3g and 3g0). Yellow liquid, yield 91%; FTIR (KBr,
Acknowledgements
cmꢀ1): 2976,1741,1625,1365,1265,1165,1115,1077;1HNMR(CDCl3):
n
d
4.15 (q, J¼7.2 Hz, 1.14H), 3.86e3.65 (m, 0.57H), 3.47 (q, J¼7.2 Hz,
We thank the National Natural Science Foundation of China for
financial support (No. 20872166).
.86H), 3.35e3.09 (m, 0.57H), 3.03e2.87 (m, 0.43H), 2. 83e2.45 (m,
3.43H),1.29e1.13 (m,19H); 19FNMR(CDCl3):
d
ꢀ71.4 (s,1.29F), ꢀ71.6(s,
1.71F); ESI MS (m/z): 358 (Mþþ1). Anal. Calcd for C15H26F3NO3S: C,
Supplementary data
50.40; H, 7.33; N, 3.92. Found: C, 50.48; H, 7.35; N, 3.98.
Supplementary data associated with this article can be found in
4.2.1.8. (S)-Ethyl 5-((R)-tert-butanesulfinylimino)-6,6-dimethyl-
20
3-trifluoromethyl)heptanoate (3h). Yellow liquid, yield 90%; [a]
D
ꢀ100.1 (c 0.85, CHCl3); FTIR (KBr, cmꢀ1):
n 2966, 2872, 1738, 1611,
1478, 1393, 1367, 1299, 1267, 1220, 1164, 1111, 1073, 1029; 1H NMR
References and notes
(CDCl3):
1H), 2.97e2.85 (m, 1H), 2.70e2.49 (m, 2H), 1.35e1.14 (m, 21H); 13C
NMR (CDCl3):
187.1, 170.7, 127.1 (q, J¼280.1 Hz), 61.1, 57.7, 44.0,
d
4.15 (q, J¼6.9 Hz, 2H), 3.67e3.46 (m, 1H), 3.27e3.21 (m,
1. For example, see: (a) Kaiser, A.; Ulmer, D.; Goebel, T.; Holzgrabe, U.; Saeftel, M.;
Hoerauf, A. Mini-Rev. Med. Chem. 2006, 6, 1231e1241; (b) Lopez, O.; Bols, M.
Iminosugars 2007, 131e152; (c) Pei, Z.; Li, X.; Geldern, T. W.; Longenecker, K.;
Pireh, D.; Stewart, K. D.; Backes, B. J.; Lai, C.; Lubben, T. H.; Ballaron, S. J.; Beno, D.
W. A.; Kempf-Grote, A. J.; Sham, H. L.; Trevillyan, J. M. J. Med. Chem. 2007, 50,
1983e1987 and references therein; (d) Nara, S.; Tanaka, R.; Eishima, J.; Hara, M.;
Takahashi, Y.; Otaki, S.; Foglesong, R. J.; Hughes, P. F.; Turkington, S.; Kanda, Y. J.
Med. Chem. 2003, 46, 2467e2473 and references therein.
d
38.1 (q, 26.9 Hz), 33.0, 29.6, 28.5, 22.5, 14.0; 19F NMR (CDCl3):
d
ꢀ71.72 (d, J¼8.2 Hz, 3F); ESI MS (m/z): 372 (Mþþ1); HRMS calcd
for C16H28F3NO3S [MþHþ]: 372.1815. Found: 372.1810.
4.2.2. Reduction of 3a. DIBAL-H (0.7 mL,1.0 M in THF) was added to
a solution of 3a (90 mg, 0.23 mmol) in THF at ꢀ78 ꢁC under N2
atmosphere. After stirring for 1 h at this temperature, the reaction
was quenched with saturated aqueous ammonium chloride
(2.5 mL). The resulting mixture was then allowed to return to room
temperature and aqueous hydrochloric acid (2.5 mL, 1.0 M) was
added dropwise. The mixture was extracted with dichloromethane
(30 mLꢂ3) and washed with saturated aqueous NaCl solution
(20 mLꢂ2). The combined organic layer was dried over anhydrous
sodium sulfate. Filtration and evaporation of the solvents afforded
the crude product, which was purified by flash column chroma-
tography on silica gel (pet. ether/EtOAc¼3/1) to give 4a.
2. (a) Buffat, M. G. P. Tetrahedron 2004, 60, 1701e1729; (b) Rodriguez, J. Stud. Nat.
Prod. Chem. 2000, 24, 573e681; (c) Bonhaus, D. W.; McNamara, J. O. Neurosci.
Biobehav. Rev. 1989, 13, 261e267.
3. For example, see: (a) Weintraub, P. M. W.; Sabol, J. S.; Kane, J. M.; Borcherding, D.
R. Tetrahedron 2003, 59, 2953e2989; (b) Xu, F.; Corley, E.; Murry, J. A.; Tschaen,
D. M. Org. Lett. 2007, 9, 2669e2672; (c) Davis, F.; Yang, B. Org. Lett. 2003, 5,
5011e5014; (d) Kawecki, R. Tetrahedron 2001, 57, 8385e8390; (e) Watson, P. S.;
Jiang, B.; Scott, B. Org. Lett. 2000, 2, 3679e3681; (f) Davis, F.; Fang, T.; Chao, B.;
Burns, D. M. Synthesis 2000, 2106e2112.
4. (a) Smart, B. E. J. Fluorine Chem. 2001, 109, 3e11; (b) Biomedical Frontiers of
Fluorine Chemistry; Ojima, I., McCarthy, J. R., Welch, J. T., Eds.; ACS: Wash-
ington, 1996; (c) Edwards, P. N. In Organofluorine Chemistry: Principles and
Commercial Applications; Banks, R. E., Tatlow, J. C., Eds.; Plenum: New York,
NY, 1994; (d) Organofluorine Compounds in Medicinal Chemistry and Bio-
chemical Applications; Filler, R., Kobayashi, Y., Agupolskii, L., Eds.; Elsevier:
Amsterdam, 1993.
5. (a) Ruano, J. L. G.; Haro, T.; Singh, R.; Cid, M. B. J. Org. Chem. 2008, 73, 1150e1153;
(b) Bariau, A.; Jatoi, W. B.; Pierre, C.; Troin, Y.; Canet, J.-L. Eur. J. Chem. 2006,
3421e3433; (c) Spanedda, M. V.; Ourévitch, M.; Crousse, B.; Bégué, J.-P.; Bonnet-
Delpon, D. Tetrahedron Lett. 2004, 45, 5023e5025; (d) Jiang, J.; DeVita, R. J.; Doss,
G. A.; Goulet, M. T.; Wyvratt, M. J. J. Am. Chem. Soc. 1999, 121, 593e594; (e)
Okano, T.; Sakaida, T.; Eguchi, S. J. Org. Chem. 1996, 61, 8826e8830.
4.2.2.1. (3S,5R)-Ethyl 5-((R)-tert-sulfinylamido)-5-phenyl-3-(trifl-
uoromethyl)pentanoate (4a). Yellowish viscous oil, yield 90%; FTIR
(KBr, cmꢀ1):
1029; 1H NMR (CDCl3):
n
3191, 2982, 1740, 1655, 1456, 1366, 1269, 1158, 1118,
7.35e7.26 (m, 5H), 4.50e4.45 (m, 1H), 4.17
d